HHS is reviving a rebate program for 340B drug discounts after the previous pilot was blocked in court earlier this year. Providers say the change will burden already cash-strapped providers with new administrative and financial costs.
The post HHS Is Reviving Its 340B Rebate Push — And Providers Are None Too Pleased appeared first on MedCity News.
